PubMed Health⌕ Search

PubMed · 9319226

Adaptive changes in locust kicking and jumping behaviour during development

Abstract

The hind, or metathoracic, leg of a locust is specialised, enabling it to store energy that is used to extend the tibia rapidly during kicking and jumping; behaviours which share a common motor pattern. This study describes developmental changes in kicking and jumping behaviour and relates these changes to the development of the exoskeleton and jumping performance. In mature adults and intermoult larvae, the exoskeleton is strong and kicks can readily be elicited. Before and after the adult moult, when the exoskeleton is weak, kicks can be elicited less frequently, thus avoiding skeletal damage. At these times, animals do not generate the adult motor pattern for kicking, so that extension of the tibia is powered by direct muscle contraction, rather than through the release of stored energy. The muscles of all newly moulted animals are capable of generating sufficient force to damage the leg, but 14 days later the muscles can rarely generate sufficient force to damage the leg. To mimic the forces generated during the preparation for a kick, when the flexor and extensor tibiae muscles co-contract, the extensor muscle was stimulated electrically at a range of frequencies and the nature and occurrence of the resulting mechanical damage to components of the skeleton were assessed over a 14 day period following the adult moult. In newly moulted animals, the proximal femur partially collapses and thus protects the leg from damage before the muscles generate sufficient force to damage chronically other components of the leg. This partial collapse of the femur is reversible when the extensor muscle is activated at low frequency, but high frequencies cause permanent damage. The muscles of all animals 1 day after the moult are also capable of generating sufficient force to damage the leg, but the proximal tibia breaks most commonly in the region where the extensor muscle apodeme attaches. 5 days after the moult, the muscles in only 50 % of animals can damage the leg and most commonly the extensor muscle apodeme breaks. In mature animals, the only structure that fails is the extensor muscle apodeme, which fractures close to its point of attachment to the tibia. Damaging a metathoracic leg can significantly decrease the ability of a locust to jump and to compete for mates. Changes in the likelihood of damage to a metathoracic leg occur at predictable stages of development. Locust behaviour is modified during development, avoiding such damage.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Norman. 1995. Adaptive changes in locust kicking and jumping behaviour during development. https://doi.org/10.1242/jeb.198.6.1341

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗